The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET study
Jonas Hannestad(UCB Pharma (Belgium)), Richard E. Carson(Yale Cancer Center), Nabeel Nabulsi(Yale Cancer Center), Nicole DellaGioia(Yale University), Jae‐Yun Lee(Yale University), Brian Pittman(Yale University), Irina Esterlis(United States Department of Veterans Affairs), Keunpoong Lim(Yale University), Daniel Pelletier(University of Southern California), Kevin C. O’Connor(Yale University), Jean‐Dominique Gallezot(Yale Cancer Center)
Cited by 203
Related Papers
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Dissociated Pattern of Activity in Visual Cortices and Their Projections During Human Rapid Eye Movement Sleep
|Science|1998|478
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
|Nature Reviews Neurology|2016|413
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
|Proceedings of the National Academy of Sciences|2015|349
Synthesis and Preclinical Evaluation of<sup>11</sup>C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
|Journal of Nuclear Medicine|2016|320